News

Medigene's PD1-41BB switch receptor improves TCR-T cell functionality against solid tumors

SHOW RELEASE

Medigene extends cash reach into the first quarter of 2023

SHOW RELEASE

Medigene provides Q2 update and 6M report 2020

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Medigene reports on Annual General Meeting 2021

SHOW RELEASE

Medigene presents compelling in vivo data for use of PD1-41BB-enhanced TCR-T cells against solid tumors

SHOW RELEASE

Medigene provides Q1 2021 update

SHOW RELEASE

Medigene presents new data on components of solid cancer TCR-T therapies at CIMT

SHOW RELEASE

Identification of ten novel tumor-specific antigens immunogenic for T cells

SHOW RELEASE

AACR data show characteristics of Medigene's lead TCR candidate against solid tumors

SHOW RELEASE

Participation at upcoming virtual conferences

SHOW RELEASE

Publication of research on co-receptor independent MAGE-A4-specific T cell receptor

SHOW RELEASE

Medigene provides results for fiscal year 2020 and outlook

SHOW RELEASE

Change in the Executive Management Board

SHOW RELEASE

Poster presentations at AACR 2021 Annual Meeting

SHOW RELEASE